Innovation in Recognizing, Diagnosing and Treating Individuals with ABI

Presented at the Hamilton Health Sciences 25th Annual Conference on Neurobehavourial Rehabilitation in ABI | May 3, 2018

Posted May 31, 2018
Share on Facebook Share on Twitter Share on Linkedin Share on Google+ Share By Email

VIDEO – On May 3, 2018, David MacDonald, a Partner at Thomson Rogers, and Dr. Dinesh Kumbhare, Associate Clinical Professor at Medicine/Physical Medicine and Rehabilitation and Rheumatology co-presented at the 25th Annual Hamilton ABI Conference.

Presentation Synopsis:

With reduced funding for community-based services both in the public and community-based spheres, innovation in recognizing, diagnosing and treating survivors is especially essential.

Building on the work of HHSC’s own Dr. Michael Noseworthy and Dr. Dinesh Kumbhare, the coalescing of authoritative studies and peer-reviewed journal articles confirm that Functional MRI testing is providing ground-breaking certainty and “positive findings” demonstrating the presence of an impact upon the neurological functioning of concussion/mild ABI to moderate and severe ABI.

Functional MRI neuroradiological testing can visualize the functional and physiological sequelae of minor, moderate and severe ABI. Identification of functional impairments using fMRI testing results can enhance proper diagnosis of these injuries and help identify appropriate rehabilitation and treatment interventions.

The opportunity for identification of brain injury sequelae with the fMRI means fMRI costs may be appropriately funded by benefit providers.

For survivors of ABI arising from car accident trauma, once these positive findings are correlated with Extended Glasgow Coma Scale test results, ABI survivors, working with skilled clinicians and counsel may gain access to funding for rehabilitation and treatment they require for their catastrophic and non-catastrophic ABI impairments.

Share on Facebook Share on Twitter Share on Linkedin Share on Google+ Share By Email